Sino Medical Sciences Hits Day High with Strong 5.33% Intraday Surge

Sino Medical Sciences Technology, Inc., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 5.33% on March 24, 2026. The stock reached an intraday high of CNY 20.16, reflecting its strong performance relative to the China Shanghai Composite, which rose by 1.78% on the same day. Over the past year, Sino Medical has delivered impressive returns of 91.81%, significantly outperforming the broader market's 15.17% gain. Despite a challenging week with a decline of 6.46%, the company has maintained a positive year-to-date performance of 4.68%. Financial metrics indicate a mixed picture; while the company has reported a notable increase in operating cash flow and pre-tax profit, it also faces challenges with a low return on capital employed and negative net worth. The stock's price-to-book ratio stands at 7.11, suggesting a premium valuation in the context of its financial performance. Overall, Sino Medical Sciences Technology, Inc. continues to navigate a complex landscape, balancing growth potential with underlying financial challenges.